Pharmaids Pharmaceuticals' Q1 FY25 Results Receive 'Strong Sell' Rating from MarketsMOJO

Aug 13 2024 09:11 PM IST
share
Share Via
Pharmaids Pharmaceuticals, a microcap company in the pharmaceutical industry, reported flat financial results for the quarter ending March 2024. Despite receiving a 'Strong Sell' call from MarketsMojo, the company remains a key player in the market and is focused on improving its performance. Investors are advised to monitor the company's progress and consider MarketsMojo's call when evaluating the stock.

Pharmaids Pharmaceuticals, a microcap company in the pharmaceutical industry, has recently announced its financial results for the quarter ending March 2024. The results, declared on August 13, 2024, have received a ‘Strong Sell’ call from MarketsMOJO, a leading financial analysis firm.

The company’s financial performance for the quarter has been flat, with a score of 0, showing no significant improvement from the previous quarter’s score of -7. This could be attributed to various factors such as market conditions, competition, and internal operations.


Despite the flat performance, Pharmaids Pharmaceuticals remains a key player in the pharmaceutical industry, catering to the needs of the microcap market. The company continues to focus on its core strengths and is constantly striving to improve its financial performance.


Investors and stakeholders of Pharmaids Pharma are advised to closely monitor the company’s progress and make informed decisions based on their individual risk appetite. MarketsMOJO’s ‘Strong Sell’ call should be taken into consideration while evaluating the company’s stock.


Overall, Pharmaids Pharmaceuticals’ financial results for the quarter ending March 2024 may not be as promising as expected, but the company remains a significant player in the microcap pharmaceutical market.


{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Pharmaids Pharmaceuticals Ltd is Rated Strong Sell
Dec 25 2025 12:57 PM IST
share
Share Via
Why is Pharmaids Pharma falling/rising?
Dec 17 2025 01:07 AM IST
share
Share Via
Why is Pharmaids Pharma falling/rising?
Nov 17 2025 11:01 PM IST
share
Share Via
Why is Pharmaids Pharma falling/rising?
Nov 14 2025 11:01 PM IST
share
Share Via
Are Pharmaids Pharma latest results good or bad?
Nov 12 2025 07:31 PM IST
share
Share Via